New injection shows promise for rare eye disease
NCT ID NCT05392179
First seen May 09, 2026 · Last updated May 09, 2026
Summary
This study tested an experimental drug called ADX-2191 in 8 adults with retinitis pigmentosa caused by specific gene mutations. Participants received injections into the worse-seeing eye to see if the treatment is safe and can help preserve vision. The goal is to slow or control the disease, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke Eye Center
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.